Francesc Salvà

813 total citations
34 papers, 467 citations indexed

About

Francesc Salvà is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Francesc Salvà has authored 34 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Francesc Salvà's work include Colorectal Cancer Treatments and Studies (26 papers), Genetic factors in colorectal cancer (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Francesc Salvà is often cited by papers focused on Colorectal Cancer Treatments and Studies (26 papers), Genetic factors in colorectal cancer (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Francesc Salvà collaborates with scholars based in Spain, Italy and Palestinian Territory. Francesc Salvà's co-authors include Javier Ros, Josep Tabernero, Élena Elez, Iosune Baraibar, N. Saoudi Gonzalez, Giulia Martini, Guillem Argilés, Nuria Mulet, Davide Ciardiello and Ariadna García and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Francesc Salvà

28 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesc Salvà Spain	13	338	151	132	113	92	34	467
N. Saoudi Gonzalez Spain	12	310 0.9×	139 0.9×	130 1.0×	100 0.9×	129 1.4×	51	447
Erika Martinelli Italy	5	297 0.9×	94 0.6×	108 0.8×	103 0.9×	85 0.9×	11	422
Sanne C.F.A. Huijberts Netherlands	12	360 1.1×	146 1.0×	351 2.7×	132 1.2×	135 1.5×	18	616
Vincenzo De Falco Italy	12	244 0.7×	59 0.4×	144 1.1×	88 0.8×	90 1.0×	38	396
Krittiya Korphaisarn Thailand	13	362 1.1×	183 1.2×	97 0.7×	129 1.1×	122 1.3×	42	532
Claire Gallois France	12	368 1.1×	172 1.1×	122 0.9×	126 1.1×	95 1.0×	47	540
Maria Banzi Italy	14	382 1.1×	102 0.7×	117 0.9×	161 1.4×	94 1.0×	49	500
Annett Maderer Germany	12	254 0.8×	77 0.5×	96 0.7×	161 1.4×	72 0.8×	25	440
Chun‐Chieh Wu Taiwan	12	200 0.6×	58 0.4×	187 1.4×	171 1.5×	87 0.9×	32	466
Eleonora Lai Italy	14	315 0.9×	55 0.4×	205 1.6×	145 1.3×	154 1.7×	46	572

Countries citing papers authored by Francesc Salvà

Since Specialization

Citations

This map shows the geographic impact of Francesc Salvà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Salvà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Salvà more than expected).

Fields of papers citing papers by Francesc Salvà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesc Salvà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Salvà. The network helps show where Francesc Salvà may publish in the future.

Co-authorship network of co-authors of Francesc Salvà

This figure shows the co-authorship network connecting the top 25 collaborators of Francesc Salvà. A scholar is included among the top collaborators of Francesc Salvà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesc Salvà. Francesc Salvà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gonzalez, N. Saoudi, et al.. (2026). Exploring resistance to immune checkpoints inhibitors in mismatch repair-deficient or microsatellite-instable colorectal cancer. Cancer Treatment Reviews. 143. 103089–103089.

Viaplana, Cristina, Joaquı́n Mateo, Francesc Salvà, et al.. (2025). A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer. Cell Reports Medicine. 6(4). 102032–102032. 3 indexed citations

Baraibar, Iosune, Francesc Salvà, Javier Ros, et al.. (2025). Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches. ESMO Open. 10(8). 105520–105520.

Baraibar, Iosune, N. Saoudi Gonzalez, Javier Ros, et al.. (2024). Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer. International Journal of Molecular Sciences. 25(13). 6967–6967. 6 indexed citations

Ros, Javier, Iosune Baraibar, N. Saoudi Gonzalez, et al.. (2024). Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver. International Journal of Molecular Sciences. 25(6). 3304–3304. 21 indexed citations

Gonzalez, N. Saoudi, Javier Ros, Iosune Baraibar, et al.. (2024). Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer. Cancers. 16(2). 412–412. 19 indexed citations

Salvà, Francesc, N. Saoudi Gonzalez, Marta Rodrı́guez, et al.. (2024). Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease. Clinical Colorectal Cancer. 23(3). 207–214.

Ros, Javier, Pablo Gómez, Giulia Martini, et al.. (2024). Real-World Data of Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil. Cancers. 16(24). 4140–4140.

Gonzalez, N. Saoudi, Francesc Salvà, Javier Ros, et al.. (2023). Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications. Cancers. 15(16). 4020–4020. 22 indexed citations

10.

Ros, Javier, Francesc Salvà, Cristina Dopazo, et al.. (2023). Liver transplantation in metastatic colorectal cancer: are we ready for it?. British Journal of Cancer. 128(10). 1797–1806. 10 indexed citations

11.

Ros, Javier, Iosune Baraibar, N. Saoudi Gonzalez, et al.. (2023). Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers. Cancers. 15(17). 4245–4245. 22 indexed citations

12.

Baraibar, Iosune, Javier Ros, N. Saoudi Gonzalez, et al.. (2023). Sex and gender perspectives in colorectal cancer. ESMO Open. 8(2). 101204–101204. 50 indexed citations

13.

Ros, Javier, N. Saoudi Gonzalez, Francesc Salvà, et al.. (2022). Ongoing and evolving clinical trials enhancing future colorectal cancer treatment strategies. Expert Opinion on Investigational Drugs. 31(3). 235–247. 4 indexed citations

14.

Ros, Javier, Iosune Baraibar, Giulia Martini, et al.. (2021). The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer. Current Treatment Options in Oncology. 22(12). 113–113. 14 indexed citations

15.

Elez, Élena, Javier Ros, Giulia Martini, et al.. (2021). LBA-3 Integrated analysis of cell-free DNA (cfDNA) BRAF mutant allele fraction (MAF) and whole exome sequencing in BRAFV600E metastatic colorectal cancer (mCRC) treated with BRAF-antiEGFR +/- MEK inhibitors. Annals of Oncology. 32. S226–S227. 10 indexed citations

16.

Baraibar, Iosune, Oriol Mirallas, N. Saoudi Gonzalez, et al.. (2021). Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer. Cancers. 13(24). 6311–6311. 42 indexed citations

17.

Baraibar, Iosune, Francesc Salvà, R. Comas, et al.. (2021). Young-onset colorectal cancer: A call for action.. Journal of Clinical Oncology. 39(15_suppl). 10563–10563. 1 indexed citations

18.

Marín, Sergio, et al.. (2020). Cost-minimisation analysis of rectal cancer neoadjuvant chemoradiotherapy based on fluoropyrimidines (capecitabine versus 5-fluorouracil). European Journal of Hospital Pharmacy. 28(e1). e13–e17. 2 indexed citations

19.

Miarons, Marta, María Roca, & Francesc Salvà. (2020). The role of pro‐, pre‐ and symbiotics in cancer: A systematic review. Journal of Clinical Pharmacy and Therapeutics. 46(1). 50–65. 11 indexed citations

20.

Baraibar, Iosune, Javier Ros, Nuria Mulet, et al.. (2020). Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update. Expert Review of Molecular Diagnostics. 20(7). 653–664. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact